Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage

Anesthesiology

Volumn 104, Issue 4, 2006, Pages 658-666

  Weiss, Nicolas ^a   Sanchez Peña, Paola ^a   Roche, Sabine ^a   Beaudeux, Jean L ^b   Colonne, Chantal ^a   Coriat, Pierre ^a   Puybasset, Louis ^a,c  

^a Department of Anesthesiology and Critical Care ^*

^b Biochemistry Department   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN S100B;

ADULT; ANEURYSM CLIP; ANEURYSM SURGERY; ARTICLE; BRAIN ARTERY ANEURYSM; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FISHER EXACT TEST; GLASGOW OUTCOME SCALE; HEMOCONCENTRATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROSURGERY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SUBARACHNOID HEMORRHAGE; TIME;

ADULT; AGED; FEMALE; HUMANS; INTRACRANIAL ANEURYSM; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PROGNOSIS; ROC CURVE; S100 PROTEINS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 33645652110     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200604000-00008     Document Type: Article

References (39)

1. Heizmann CW: Ca2+-binding S100 proteins in the central nervous system. Neurochem Res 1999; 24:1097-100
2. Stefansson K, Wollmann RL, Moore BW: Distribution of S-100 protein outside the central nervous system. Brain Res 1982; 234:309-17
3. Martens P, Raabe A, Johnsson P: Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998; 29:2363-6
4. Raabe A, Grolms C, Seifert V: Serum markers of brain damage and outcome prediction in patients after severe head injury. Br J Neurosurg 1999; 13:56-9
5. Woertgen C, Rothoerl RD, Metz C, Brawanski A: Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999; 47:1126-30
6. Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A: Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien) 1997; 139:1161-4
7. Ingebrigtsen T, Waterloo K, Jacobsen EA, Langbakk B, Romner B: Traumatic brain damage in minor head injury: Relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery 1999; 45:468-75
8. Buttner T, Weyers S, Postert T, Sprengelmeyer R, Kuhn W: S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke 1997; 28:1961-5
9. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J: Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: Correlation with injury severity and clinical outcome. Stroke 2003; 34:637-42
10. Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28:1956-60
11. Wiesmann M, Missler U, Hagenstrom H, Gottmann D: S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1997; 139:1155-60
12. Takayasu M, Shibuya M, Kanamori M, Suzuki Y, Ogura K, Kageyama N, Umekawa H, Hidaka H: S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 1985; 63:417-20
13. Persson L, Hardemark H, Edner G, Ronne E, Mendel-Hartvig I, Pahlman S: S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: A potential marker of brain damage. Acta Neurochir (Wien) 1988; 93:116-22
14. Hardemark HG, Almqvist O, Johansson T, Pahlman S, Persson L: S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: Relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction. Acta Neurochir (Wien) 1989; 99:135-44
15. Kay A, Petzold A, Kerr M, Keir G, Thompson E, Nicoll J: Temporal alterations in cerebrospinal fluid amyloid beta-protein and apolipoprotein E after subarachnoid hemorrhage. Stroke 2003; 34:e240-3
16. Sen J, Belli A, Petzold A, Russo S, Keir G, Thompson EJ, Smith M, Kitchen N: Extracellular fluid S100B in the injured brain: A future surrogate marker of acute brain injury? Acta Neurochir (Wien) 2005; 147:897-900
17. Raabe A, Grolms C, Keller M, Donnert J, Sorge O, Seifert V: Correlation of computed tomography findings and serum brain damage markers following severe head injury. Acta Neurochir (Wien) 1998; 140:787-91
18. Wijdicks EF, Kallmes DF, Manno EM, Fulgham JR, DG P: Subarachnoid hemorrhage: Neurointensive care and aneurysm repair Mayo Clin Proc 2005; 80:550-9
19. Drake C: Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988; 68:985-6
20. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980; 6:1-9
21. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1975; 1:480-4
22. International Subarachnoid Aneurysm trial (ISAT) Collaborative Group: International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients ruptured intracranial aneurysms: A randomised trial. Lancet 2002; 360:1267-74
23. Korinek AM, Reina M, Boch AL, Rivera AO, De Bels D, Puybasset L: Prevention of external ventricular drain-related ventriculitis. Acta Neurochir (Wien) 2005; 147:39-46
24. Okada Y, Shima T, Nishida M, Yamane K, Hatayama T, Yamanaka C, Yoshida A: Comparison of transcranial Doppler investigation of aneurysmal vasospasm with digital subtraction angiographic and clinical findings. Neurosurgery 1999; 45:443-9
25. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, van Effenterre R: Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: Preliminary results. Am J Neuroradiol 2004; 25:1067-76
26. Beaudeux JL, Leger P, Dequen L, Gandjbakhch I, Coriat P, Foglietti MJ: Influence of hemolysis on the measurement of S-100beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 2000; 46:989-90
27. Fagnart OC, Sindic CJ, Laterre C: Particle counting immunoassay of S100 protein in serum: Possible relevance in tumors and ischemic disorders of the central nervous system. Clin Chem 1988; 34:1387-91
28. Persson L, Hardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, Pahlman S: S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 1987; 18:911-8
29. Petzold A, Keir G, Lim D, Smith M, Thompson EJ: Cerebrospinal fluid (CSF) and serum S100B: Release and wash-out pattern. Brain Res Bull 2003; 61:281-5
30. Sundt TMJ, Kobayashi S, Fode NC, Whisnant JP: Results and complications of surgical management of 809 intracranial aneurysms in 722 cases: Related and unrelated to grade of patient, type of aneurysm, and timing of surgery. J Neurosurg 1982; 56:753-765
31. Kopera M, Majchrzak H, Kaspera W: Prognostic factors in patients with-intracerebral hematoma caused by ruptured middle cerebral artery aneurysm. Neurol Neurochir Pol 1999; 33:389-401
32. Braun V, Rath S, Antoniadis G, Richter H-P, Born W: Treatment and outcome of aneurysmal subarachnoid haemorrhage in the elderly patient. Neuroradiology 2005; 47:215-21
33. Edouard A, Felten M, Hebert J, Cosson C, Martin L, Benhamou D: Incidence and significance of cardiac troponin I release in severe trauma patients. ANESTHESIOLOGY 2004; 101:1262-8
34. Macrea LM, Tramer MR, Walder B: Spontaneous subarachnoid hemorrhage and serious cardiopulmonary dysfunction: A systematic review. Resuscitation 2005; 65:139-48
35. Miss JC, Kopelnik A, Fisher LA, Tung PP, Banki NM, Lawton MT, Smith WS, Dowd CF, Zaroff JC: Cardiac injury after subarachnoid hemorrhage is independent of the type of aneurysm therapy. Neurosurgery 2004; 55:1244-50
36. Raabe A, Kopetsch O, Woszczyk A, Lang J, Gerlach R, Zimmermann M, Seifert V: S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients. Neurol Res 2004; 26:440-5
37. Foerch C, Bettina O, Singer OC, Neumann-Haefelin T: Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke 2004; 35:2160-4
38. Usui A, Kato K, Abe T, Murase M, Tanaka M, Takeuchi E: S-100ao protein in serum during acute myocardial infarction. Clin Chem 1989; 35:1942-4
39. Riou B: Troponin: Important in severe trauma and a first step in the biological marker revolution. ANESTHESIOLOGY 2004; 101:1259-60